Windtree Therapeutics Delisted: Delisting Highlights Challenges of Crypto-Centric Strategy

Windtree Therapeutics, facing financial struggles despite heavy investments in cryptocurrency, will be delisted from Nasdaq on August 21st, 2025. The company’s strategy to shift its treasury towards cryptocurrencies has not yielded the expected institutional support. This delisting underscores the challenges associated with integrating crypto into traditional corporate finance models.